Emma C Mann
September 16, 2024 | Law.com
Federal Circuit Decision Clarifies Obviousness-Type Double Patenting and Patent Term Adjustments In 'Allergan v. MSN Laboratories'On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware's application of the Federal Circuit precedent in In re: Cellect to invalidate a claim in an earlier-filed parent application over admittedly patentably indistinct claims in later-filed (and earlier-expired) child patents. This decision has resolved some substantial questions about the application of obviousness-type double patenting that had been raised by last year's In re Cellect decision.
By Maia H. Harris and Emma C. Mann
7 minute read
Trending Stories
- 1Four Law Firm Mergers That Could Make Sense
- 2'Shocking, Distasteful…' A&O Shearman Lawyers Slam Johannesburg Office Closure
- 3How I Made Practice Group Chair: 'People Skills Are Key. None of Us Succeed Alone,' Says Elaine Blais of Goodwin Procter
- 4Hogan Lovells Will Shutter 3 International Offices Amid Strategy to Follow 'Greatest Opportunities'
- 5Law Clerks Can't Seek Post-Clerkship Jobs With Political Orgs, Ethics Guidance Says
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read